The prevention of ill-effect as caused by CD3 specific binding domains

The prevention of ill-effect as caused by CD3 specific binding domains

  • CN 103,533,943 B
  • Filed: 10/27/2011
  • Issued: 02/13/2018
  • Est. Priority Date: 11/10/2010
  • Status: Active Grant
First Claim
Patent Images

1. dexamethasone is being prepared for improving, treating or preventing the nerve as caused by the administration of CD3 binding structural domains in patientThe purposes in the medicine of adverse events is learned, wherein before the CD3 binding structural domains of the first dosage are applied and applyingBefore the CD3 binding structural domains of second dosage and/or the 3rd dosage, using the medicine, also, wherein described neurologyAdverse events are sensory disturbance, epilepsy, encephalopathic, confusion, incoordination, appraxia, aphasis, illusion, paresis, trembled or fixedOne or more into obstacle.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×